Payment overview · 2025
General Payments
$118.55
1 reported records · 1 companies
Healthcare provider profile · identity verified
Dana Brown
Allopathic & Osteopathic Physicians|Family Medicine · VERONA, PA · NPI 1851331995
Verified facts
What the public records show
CMS Open Payments records show Dana Brown received $118.55 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $118.55 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $118.55 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 813 | 219 |
| Lisinopril | Lisinopril | 510 | 148 |
| Amlodipine Besylate | Amlodipine Besylate | 420 | 110 |
| Metoprolol Succinate | Metoprolol Succinate | 322 | 81 |
| Losartan Potassium | Losartan Potassium | 317 | 87 |
| Levothyroxine Sodium | Levothyroxine Sodium | 308 | 81 |
| Tamsulosin Hcl | Tamsulosin Hcl | 295 | 74 |
| Hydrochlorothiazide | Hydrochlorothiazide | 284 | 78 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 281 | 77 |
| Omeprazole | Omeprazole | 280 | 69 |
| Simvastatin | Simvastatin | 262 | 76 |
| Eliquis | Apixaban | 248 | 43 |
| Pantoprazole Sodium | Pantoprazole Sodium | 232 | 61 |
| Sertraline Hcl | Sertraline Hcl | 224 | 61 |
| Jardiance | Empagliflozin | 194 | 41 |
| Gabapentin | Gabapentin | 187 | 39 |
| Trazodone Hcl | Trazodone Hcl | 171 | 33 |
| Metformin Hcl | Metformin Hcl | 163 | 44 |
| Metoprolol Tartrate | Metoprolol Tartrate | 157 | 47 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 155 | 50 |
| Escitalopram Oxalate | Escitalopram Oxalate | 139 | 28 |
| Famotidine | Famotidine | 139 | 40 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 137 | 37 |
| Alendronate Sodium | Alendronate Sodium | 136 | 37 |
| Fluticasone Propionate | Fluticasone Propionate | 125 | 46 |
| Allopurinol | Allopurinol | 119 | 30 |
| Pravastatin Sodium | Pravastatin Sodium | 116 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 115 | 27 |
| Prednisone | Prednisone | 113 | 85 |
| Lorazepam | Lorazepam | 111 | 25 |
| Atenolol | Atenolol | 110 | 26 |
| Metformin Hcl Er | Metformin Hcl | 102 | 35 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 96 | 20 |
| Finasteride | Finasteride | 88 | 25 |
| Furosemide | Furosemide | 86 | 30 |
| Potassium Chloride | Potassium Chloride | 84 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 79 | 27 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 78 | 22 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 75 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 73 | 20 |
| Carvedilol | Carvedilol | 71 | 22 |
| Glipizide Er | Glipizide | 70 | 16 |
| Donepezil Hcl | Donepezil Hcl | 67 | 18 |
| Ozempic | Semaglutide | 66 | 11 |
| Meloxicam | Meloxicam | 63 | 14 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 62 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 60 | 16 |
| Xarelto | Rivaroxaban | 58 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 57 | 18 |
| Alprazolam | Alprazolam | 53 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 52 | 12 |
| Spironolactone | Spironolactone | 49 | 13 |
| Hydrocortisone | Hydrocortisone | 45 | 17 |
| Warfarin Sodium | Warfarin Sodium | 44 | 12 |
| Buspirone Hcl | Buspirone Hcl | 42 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 41 | suppressed |
| Rybelsus | Semaglutide | 40 | suppressed |
| Bupropion Xl | Bupropion Hcl | 39 | 12 |
| Memantine Hcl | Memantine Hcl | 39 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 39 | 11 |
| Levetiracetam | Levetiracetam | 36 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 36 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 35 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 34 | 13 |
| Bupropion Hcl Sr | Bupropion Hcl | 34 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | suppressed |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Mirtazapine | Mirtazapine | 27 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 26 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 25 | suppressed |
| Ibuprofen | Ibuprofen | 24 | 11 |
| Trulicity | Dulaglutide | 24 | suppressed |
| Methylprednisolone | Methylprednisolone | 23 | 20 |
| Tradjenta | Linagliptin | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 21 |
| Sildenafil Citrate | Sildenafil Citrate | 22 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 22 | suppressed |
| Rivastigmine | Rivastigmine | 21 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | suppressed |
| Acyclovir | Acyclovir | 19 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 19 | suppressed |
| Glipizide | Glipizide | 19 | suppressed |
| Telmisartan | Telmisartan | 19 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 19 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 17 | suppressed |
| Indapamide | Indapamide | 17 | suppressed |
| Lansoprazole | Lansoprazole | 17 | suppressed |
| Methimazole | Methimazole | 17 | suppressed |
| Nifedipine Er | Nifedipine | 17 | suppressed |
| Synthroid | Levothyroxine Sodium | 17 | suppressed |
| Cephalexin | Cephalexin | 16 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 16 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Jantoven | Warfarin Sodium | 15 | suppressed |
| Klor-Con M20 | Potassium Chloride | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 15 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Xultophy 100-3.6 | Insulin Degludec/Liraglutide | 14 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 13 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 13 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Azithromycin | Azithromycin | 12 | 11 |
| Carvedilol Er | Carvedilol Phosphate | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Ibu | Ibuprofen | 12 | suppressed |
| Irbesartan | Irbesartan | 12 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 12 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 12 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | 11 |
| Clonazepam | Clonazepam | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | 11 |
| Epinephrine | Epinephrine | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Lovastatin | Lovastatin | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Naproxen | Naproxen | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $118.55 · 1 records | AstraZeneca Pharmaceuticals LP | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error